Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Researchers discover a new antibody type

Researchers have made a discovery that contradicts previous understanding that an antibody only eliminates a specific subgroup of bacteria.

16 May 2018

First genomic survey of gonorrhea maps antibiotic resistance across Europe

The first European-wide genomic survey of gonorrhea has mapped antibiotic resistance in this sexually transmitted disease throughout the continent.

16 May 2018

Drug-resistant staph infections found to be deadly, but less costly

Staph infections, whether MRSA (resistant to methicillin) or susceptible, are important and deadly. Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a new national analysis shows.

15 May 2018

Scientists uncover new target for MRSA

Researchers at Michigan State University have identified why methicillin-resistant Staphylococcus aureus or MRSA is so resilient, a finding that could pave the way for potential new treatments.

15 May 2018

New study aims to turn MRSA’s strength against it

Antibiotic-resistant infections cause more than 30,000 deaths annually in the U.S. alone. The majority of those are caused by methicillin-resistant Staphylococcus aureus, more commonly known as MRSA, which can turn routine medical operations into near-death battles.

15 May 2018

Research may pave way for new C. diff antitoxins and anti-cancer drugs

Researchers from the University of California, Irvine and Harvard University have discovered how the Clostridium difficile toxin B recognizes the human Frizzled protein, the receptor it uses to invade intestinal cells and lead to deadly gastrointestinal infections.

14 May 2018

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

14 May 2018

Oral antibiotic use may increase risk of developing kidney stones, shows study

Pediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones.

11 May 2018

Addressing Antimicrobial Resistance Through Industry

Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.

11 May 2018

New study links oral antibiotics with increased risk of kidney stones

The potential to promote antibiotic resistance in bacteria isn't the only reason to avoid using antibiotics when possible.

11 May 2018

New study shows MRSA is no more expensive to treat than MSSA

A new study from the Center for Disease Dynamics, Economics & Policy, with collaborators from Johns Hopkins University and University of Texas Southwestern Medical Center, found that infections caused by one of the most common drug resistant bacteria in the US--methicillin-resistant Staphylococcus aureus, known as MRSA--are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria.

10 May 2018

STEM workshop highlights the need to impart advanced training and education on clean, sustainable pharmaceutical manufacturing

DSM Sinochem Pharmaceuticals, global leader in sustainable antibiotics, in collaboration with the Indian Institute of Technology, New Delhi organized a workshop today on 'Sustainability through Excellence in Manufacturing (STEM)' to impart advanced training and education to industry stakeholders on high quality, clean and sustainable pharmaceutical manufacturing.

9 May 2018

OU researchers receive $5.7 million NIH grant to accelerate antibiotic discovery

University of Oklahoma professors, Helen Zgurskaya and Valentin Rybenkov, and team are addressing the challenge and critical need for new antibiotics that can fight infections caused by the multi-drug resistant bacterium, Pseudomonas aeruginosa, considered an urgent threat by the Centers for Disease Control and Prevention.

7 May 2018

Discovery could be used as starting point for development of new antibiotics

According to the WHO, around 700,000 people die every year as a result of antibiotic resistance. In Germany, around 6,000 people die every year because treatment with antibiotics is not effective.

7 May 2018

Study shows how bacterial toxins can cripple normal cellular activity

Bacterial toxins can wreak mass havoc within cells by shutting down multiple essential functions at once, a new study has found.

4 May 2018

UTHealth experts reveal how everyone can make a difference in infection control

When it comes to the examination room at your health care clinic, you might think that avoiding catching the flu or other more deadly viruses is out of your hands, so to speak.

4 May 2018

Study examines trends of antibiotic-resistant A. baumannii infections in children

In the first national study of the prevalence of antibiotic-resistant Acinetobacter baumannii infections in children across the US, researchers from Center for Disease Dynamics, Economics, & Policy (CDDEP) in Washington, DC and Rush University in Chicago, IL examined national and regional trends of antibiotic resistance in clinical specimens over a 13-year period.

3 May 2018

Antibiotic-resistant bacteria could help clear antibiotic contamination

Research has revealed how bacteria are able to obtain the nutrients they need to survive from antibiotics.

1 May 2018

Researchers identify how smaller hospitals can reduce inappropriate use of antibiotics

Researchers at Intermountain Healthcare and University of Utah Health in Salt Lake City have completed a study identifying how community hospitals with fewer than 200 beds can develop antibiotic stewardship programs that work to prevent the growth of antibiotic-resistant organisms, or "superbugs," which are becoming more common and deadly.

30 Apr 2018